Literature DB >> 35198465

Histopathological Characterization of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) and Comparison with Maculopapular Drug Rash (MPDR).

Rashmi Jindal1, Robin Chugh1, Payal Chauhan1, Nadia Shirazi2, Yashwant S Bisht1.   

Abstract

INTRODUCTION: Drug rash with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous adverse drug reaction (cADR) associated with significant systemic involvement and greater mortality. Variable patterns of inflammation are reported in the histopathology of DRESS. However, the role of histopathology in predicting systemic involvement and thus final outcome remains elusive. In the present study, we aim to review clinical and histopathological characteristics of patients with DRESS and compare their histopathology with that of maculopapular drug rash.
MATERIALS AND METHODS: A retrospective analysis of cases of cADRs diagnosed from July 2014 to July 2020 at a single tertiary care institute was performed. A RegiSCAR score of ≥4 was used to recruit patients as DRESS. Patients with a probable/definite diagnosis of cADR on the basis of Naranjo criteria and presenting with exanthem attaining a RegiSCAR score of ≤3 were categorized as MPDR. Correlation of histopathology characteristics with the investigative profile of patients with DRESS was done. MPDR and DRESS were also compared for histopathological characteristics using Chi-square test. Further histopathology of patients with drug rash (both DRESS and MPDR) having systemic involvement was compared with those without systemic involvement to identify specific predictors.
RESULTS: Eighteen patients of DRESS and 20 of MPDR fulfilled the inclusion criteria. Most common drugs implicated were anticonvulsants (27.8%). Characteristic findings seen on histopathology in patients with DRESS were epidermal spongiosis (94.5%), epidermal dyskeratosis (33.3%), lymphocytic exocytosis (88.9%), interface vacuolization (77.8%), papillary dermal edema (100%). and perivascular lymphocytic infiltrate (100%). Findings in favor of DRESS compared to MPDR were lymphocytic exocytosis (P < 0.001), interface vacuolization (P = 0.002), severe spongiosis (P = 0.046), severe papillary dermal edema (P = 0.018), and higher density of dermal infiltrate (P = 0.005). Lymphocyte exocytosis and distribution and density of dermal inflammatory infiltrate correlated significantly with deranged kidney function.
CONCLUSION: Histopathology revealing prominent basal vacuolization, spongiosis, and dense dermal infiltrate suggests DRESS. Lymphocyte exocytosis and distribution and density of dermal inflammatory infiltrate predict renal involvement. Copyright:
© 2022 Indian Dermatology Online Journal.

Entities:  

Keywords:  Basal vacuolization; DRESS; maculopapular drug rash

Year:  2022        PMID: 35198465      PMCID: PMC8809173          DOI: 10.4103/idoj.idoj_452_21

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


Introduction

Drug rash with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous adverse drug reaction (cADR) characterized by a widespread exanthem along with hematological and solid organ abnormalities predominantly affecting liver and kidney.[1] Its incidence varies from 1 in 1,000 to 1 in 10,000 drug exposures with 10% mortality, primarily due to liver failure.[23] The initial description of DRESS dates back to 1940, when a.cADR was identified with hydantoin intake typified by rash, fever, lymphadenopathy, and systemic upset. Similar reports with other anticonvulsants led to the terminology, anticonvulsants hypersensitivity syndrome.[2] But with the description of other drugs causing similar presentation, various names including drug-induced hypersensitivity syndrome and drug-induced delayed multi-organ hypersensitivity syndrome were used. DRESS, however, appears to be a commonly used terminology now. Though clinico-investigative literature on DRESS is plentiful, histopathological description is scarce. After the initial histopathological description of DRESS as drug-induced pseudo-lymphoma, various patterns have been reported, from lichenoid and erythema multiforme (EM) like to leucocytoclastic and eczematous. Role of histopathology in predicting systemic involvement and thus final outcome remains elusive. Available literature suggests a possible role of degree of keratinocyte necrosis in predicting severity of visceral involvement.[14567] Considering the range of cutaneous manifestations possible in DRESS, it is imperative to differentiate it from the much milder maculopapular drug rash (MPDR). Comparative studies differentiating DRESS from MPDR are also histopathologically limited. In the present study, we aim to correlate the histopathology of patients with DRESS with their investigative profile and compare their histopathology with patients diagnosed as MPDR. Further, histopathology of patients with drug rash (both DRESS and MPDR) having systemic involvement will be compared with those without systemic involvement to identify specific predictors.

Materials and Methods

A retrospective analysis of cases of cADRs diagnosed from July 2014 to July 2020 at a single tertiary care institute was performed after obtaining approval from Institutional Ethics Committee. A RegiSCAR score of ≥4 corresponding to probable or definite cases was used to recruit patients as DRESS.[8] In addition to data needed to calculate the RegiSCAR score, the following clinical details were retrieved and recorded: Age, gender, latency between the onset of eruptions and cutaneous biopsy, implicated drug, morphology of cutaneous lesions (diffuse erythema, purpura, pustules, and facial edema), and extent of skin involvement. To assess the visceral involvement, complete blood count, absolute eosinophil count, liver function test, and kidney function test were evaluated. RegiSCAR guidelines were followed to assess liver and kidney involvement. Further patients with a probable or definite diagnosis of cADR on the basis of Naranjo criteria and presenting with exanthem attaining a RegiSCAR score of ≤3 were categorized as MPDR in order to compare their histopathology with DRESS. Patients of both subtypes of drug rash (DRESS and MPDR) were also categorized depending on systemic involvement in order to identify specific histopathological predictors. Histopathological evaluation was performed on hematoxylin and eosin-stained archival slide sections for both DRESS and MPDR. Two investigators (RJ, NS with over 12-year experience in dermatopathology) blinded to the final diagnosis reevaluated the histopathology and any discrepancy was settled after discussion. Histopathology changes enlisted were In epidermis: Spongiosis (mild: focal spongiosis and severe: full thickness spongiosis with or without spongiotic vesicles), pustulation, keratinocyte dyskeratosis (mild: 1–10 cells/40×, severe: >10 cells/40×), basal vacuolization (mild: focal, severe: diffuse), Lymphocyte exocytosis (>10 lymphocytes/40× in minimum three fields) In dermis: Papillary dermal edema (mild: focal, severe: diffuse), infiltrate density (sparse, intermediate, or dense), composition (lymphocytes, atypical lymphocytes, neutrophils, and eosinophils), red blood cell extravasation without vasculitis, leucocytoclastic vasculitis (LCV), presence of deep dermal infiltrate. Atypical lymphocytes were defined as larger lymphocytes with enlarged hyperchromatic nuclei. LCV was defined as infiltration of vessel wall, fibrinoid necrosis, leucocyte karyorrhexis, and red blood cells extravasation. Histopathology pattern was labeled as lichenoid, EM like, eczematous, vasculitis, or pustular. When interface vacuolization with marked pigment incontinence and band-like lymphocytic infiltrate was present, it was regarded as lichenoid. In the presence of epidermal dyskeratosis, papillary dermal edema, and interface vacuolization, it was labeled as EM like. While, when severe spongiosis was seen in association with lymphocyte exocytosis, it was identified as eczematous. The data were collected and entered in MS excel 2013. Statistical analysis was performed using SPSS software version 22. Descriptive statistics were calculated for quantitative variables. Frequency along with percentage was calculated for qualitative and categorical variables. Comparison of histopathology characteristics with investigative profile of patients with DRESS was done using Chi-square test. MPDR and DRESS were also compared for histopathological characteristics using Chi-square test.

Results

Eighteen patients of DRESS fulfilled the inclusion criteria. Men and women had an equal representation (M:F ratio 1:1). Age of the patients ranged from 8 years to 75 years with a median age of 35.5 years. Most common drugs implicated were anticonvulsants (27.8%), followed by antibiotics (22.2%) and antitubercular (22.2%) drugs. The latency period between initiation of drug and development of rash varied from 8 days to 60 days. Commonest cutaneous phenotype was urticarial papular exanthem (55.6%), followed by morbilliform rash (27.8%) and erythroderma (11.1%). Facial edema was a common feature seen in 72.2% cases. Body surface area involved ranged from 40% to 90%. Blood eosinophilia was encountered in 55.6% patients and deranged liver function and renal function were seen in 55.6% and 27.8% cases, respectively [Table 1]. Characteristic findings seen on histopathology were epidermal spongiosis (94.5%), epidermal dyskeratosis (33.3%), lymphocytic exocytosis (88.9%), interface vacuolization (77.8%), papillary dermal edema (100%), and perivascular lymphocytic infiltrate (100%) [Figure 1a and c]. Interface vacuolization was focal in 44.4% cases and diffuse in 33.3% cases [Figure 2a and c]. Dermal infiltrate extended to involve deep dermis in half of the cases and in 94.5% cases, it comprised of eosinophils. In addition, 11.1% patients each had atypical lymphocytes, plasma cells, and neutrophils in the perivascular infiltrate. Red blood cells extravasation was observed in 55.5% cases; however, overt LCV was inconspicuous. In 13 of the 18 cases, histopathology could be classified into certain pattern. It was labeled as eczematous with lichenoid in three, EM like with lichenoid in two, lichenoid in three, eczematous in two, and pustular in one case. In two cases, a combination of eczematous, lichenoid, and EM-like pattern was seen [Figure 3a-d].
Table 1

Clinical characteristics of the patients with drug rash with eosinophilia and systemic symptoms (DRESS) (n=18)

Clinical characteristicsMean±SD/number (%)
Age (years)
 Mean39.00±20.65
 Median35.5
Gender
 Male9 (50%)
 Female9 (50%)
Latency (days)
 Mean17.7±12.6
Median BSA involved60%
Offending drug
 Anticonvulsants5 (27.8%)
 Antitubercular4 (22.2%)
 Antibiotics4 (22.2%)
 Allopurinol3 (16.7%)
 Aceclofenac 1 (5.5%0
 Ayurvedic1 (5.5%)
Cutaneous phenotype
 Urticarial papular exanthem10 (55.6%)
 Morbilliform rash5 (27.8%)
 Erythroderma/exfoliative dermatitis2 (11.1%)
 EM-like lesions1 (5.5%)
 Facial edema13 (72.2%)
 Purpura6 (33.3%)
 Pustules3 (16.7%)
Blood eosinophilia10 (55.6%)
Liver dysfunction10 (55.6%)
Renal dysfunction5 (27.8%)
Figure 1

(a) Superficial and deep perivascular infiltrate in DRESS (H and E 4×) with inset showing urticarial papular exanthem over back, (b) mild superficial infiltrate in MPDR (H and E 4×) with inset showing maculopapular exanthem over chest and abdomen, (c) severe spongiosis with spongiotic vesicle in DRESS (H and E 40×), (d) mild spongiosis in MPDR (H and E 40×)

Figure 2

(a) Epidermal dyskeratosis with diffuse interface vacuolization in DRESS, H and E 10×, (c) H and E 40×. (b) Epidermal dyskeratosis with focal interface vacuolization in MPDR, H and E 10×, (d) H and E 40×

Figure 3

(a) Erythema multiforme like (circle), eczematous (square), and lichenoid (rectangle) pattern in a single biopsy of DRESS (H and E 4×), (b) keratinocyte dyskeratosis with papillary dermal edema and basal vacuolar damage representing erythema multiforme like pattern, (c) spongiosis with lymphocytic exocytosis representing eczematous pattern, (d) lymphocytic infiltrate at dermo-epidermal junction representing lichenoid pattern (H and E 40×)

Clinical characteristics of the patients with drug rash with eosinophilia and systemic symptoms (DRESS) (n=18) (a) Superficial and deep perivascular infiltrate in DRESS (H and E 4×) with inset showing urticarial papular exanthem over back, (b) mild superficial infiltrate in MPDR (H and E 4×) with inset showing maculopapular exanthem over chest and abdomen, (c) severe spongiosis with spongiotic vesicle in DRESS (H and E 40×), (d) mild spongiosis in MPDR (H and E 40×) (a) Epidermal dyskeratosis with diffuse interface vacuolization in DRESS, H and E 10×, (c) H and E 40×. (b) Epidermal dyskeratosis with focal interface vacuolization in MPDR, H and E 10×, (d) H and E 40× (a) Erythema multiforme like (circle), eczematous (square), and lichenoid (rectangle) pattern in a single biopsy of DRESS (H and E 4×), (b) keratinocyte dyskeratosis with papillary dermal edema and basal vacuolar damage representing erythema multiforme like pattern, (c) spongiosis with lymphocytic exocytosis representing eczematous pattern, (d) lymphocytic infiltrate at dermo-epidermal junction representing lichenoid pattern (H and E 40×) Comparison of histopathology changes with systemic involvement in terms of deranged liver or renal function did not reveal significant histopathological predictors except for association of papillary dermal edema with renal involvement [Table 2]. Histopathology characteristics of DRESS were compared with 20 cases of MPDR recruited on the basis of previously described inclusion criteria [Table 3]. Statistically significant findings in favor of DRESS were lymphocytic exocytosis (P < 0.001), interface vacuolization (P = 0.002), severe spongiosis (P = 0.046), severe papillary dermal edema (P = 0.018), and higher density of dermal infiltrate (P = 0.005) [Figures 1a-d, 2a-d]. However, degree of epidermal dyskeratosis, tissue eosinophilia, and red blood cell extravasation was comparable in both (P > 0.05). In order to identify histopathological predictors of systemic involvement in patients presenting with drug reactions, patients of both subtypes of drug rash (DRESS and MPDR) were categorized on the basis of systemic involvement in terms of deranged liver and renal function as well as presence of blood eosinophilia. Lymphocyte exocytosis and distribution and density of dermal inflammatory infiltrate correlated significantly with deranged kidney function [Table 4]. Specific histopathological predictors could not be identified for liver involvement and blood eosinophilia.
Table 2

Comparison of histopathology changes with systemic involvement in patients with drug rash with eosinophilia and systemic symptoms (n=18)

Histopathology characteristicsLiver functionRenal functionBlood eosinophilia



Deranged (n=10)Normal (n=8)Deranged (n=5)Normal (n=13)Present (n=10)Absent (n=8)
Keratinocyte dyskeratosis
 Nil6621057
 1-10 cells/40×412341
 >10 cells/40×011010
P 0.270.160.23
Epidermal spongiosis
 Nil010110
 Mild632745
 Severe443553
P 0.410.640.49
Interface vacuolization
 Nil310422
 Mild533535
 Severe242451
P 0.370.370.23
Papillary dermal edema
 Mild8621277
 Severe223131
P 0.800.010.37
Tissue eosinophilia
 Nil010110
 Mild865977
 Severe210321
P 0.490.370.57
Table 3

Comparison of histopathology characteristics of drug rash with eosinophilia and systemic symptoms (DRESS) and maculopapular drug rash (MPDR)

Histopathology characteristicsDRESS (n=18) Number (%)MPDR (n=20) Number (%) P
Epidermal spongiosis0.046
 Nil1 (5.5)1 (5.0)
 Mild9 (50.0)17 (85.0)
 Severe8 (44.4)2 (10.0)
Epidermal dyskeratosis0.844
 Nil12 (66.7)15 (75.0)
 1-10 cells/400×5 (27.8)4 (20.0)
 >10 cells/400×1 (5.5)1 (5.0)
Lymphocyte exocytosis16 (88.9)6 (30.0)<0.001
Interface vacuolization0.002
 Nil4 (22.2)16 (80.0)
 Focal8 (44.4)3 (15.0)
 Diffuse6 33.3)1 (5.0)
Papillary dermal edema0.018
 Nil0 (0.0)4 (20.0)
 Mild14 (77.8)16 (80.0)
 Severe4 (22.2)0 (0.0)
Eosinophilia0.488
 Nil1 (5.5)0 (0.0)
 1-10/400×14 (77.8)15 (75.0)
 >10/400×3 (16.7)5 (25.0)
RBC extravasation10 (55.5)12 (60.0)0.782
Dermal infiltrate distribution0.111
 Superficial9 (50.0)15 (75.0)
 Superficial and deep9 (50.0)5 (25.0)
Density of dermal infiltrate0.005
 Sparse3 (16.7)11 (55.0)
 Intermediate9 (50.0)9 (45.0)
 Dense6 (33.3)0 (0.0)
Table 4

Comparison of histopathology changes with systemic involvement in all patients (Both DRESS and MPDR, n=38)

Histopathology characteristicLiver functionRenal functionBlood eosinophilia



Deranged (n=12)Normal (n=26)Deranged (n=11)Normal (n=27)Present (n=16)Absent (n=22)
Epidermal spongiosis
 Nil020220
 Mild818719818
 Severe464664
P 0.740.690.14
Keratinocyte dyskeratosis
 Nil621720918
 1-10 cells/40×454563
 >10 cells/40×200211
P 0.470.370.21
Lymphocyte exocytosis12101012814
P 0.070.010.35
Interface vacuolization
 Nil416416713
 Mild565647
 Severe342552
P 0.270.320.22
Papillary dermal edema
 Nil220422
 Mild7239211119
 Severe312231
P 0.080.290.33
Tissue eosinophilia
 Nil010110
 Mild11189201118
 Severe172644
P 0.310.770.41
RBC extravasation814517814
P 0.350.260.3
Dermal infiltrate distribution
 Superficial717420915
 Superficial and deep597777
P 0.470.030.34
Density of dermal infiltrate
 Sparse41011359
 Intermediate711513711
 Dense155142
P 0.570.0030.41
Comparison of histopathology changes with systemic involvement in patients with drug rash with eosinophilia and systemic symptoms (n=18) Comparison of histopathology characteristics of drug rash with eosinophilia and systemic symptoms (DRESS) and maculopapular drug rash (MPDR) Comparison of histopathology changes with systemic involvement in all patients (Both DRESS and MPDR, n=38)

Discussion

The mean age of patients with DRESS (39 ± 20.65 years) in the present study appeared younger when compared with reported literature.[17] The mean latency period between ingestion of culprit drug and onset of rash was 17.7 ± 12.6 days, corroborating with similar studies done worldwide.[17] Anticonvulsants and antimicrobials are the common culprit drugs; however, in addition, antitubercular drugs (22.2%) were also imputed in the reported study in a significant proportion of patients. This possibly reflects the high prevalence of tuberculosis in our region. DRESS is characterized by a variable clinical as well as histopathological phenotype that lacks uniformity in reported studies. Walsh et al.[1] classified the clinical presentation of DRESS into urticarial papular exanthem, morbilliform eruptions, erythroderma, and EM like. However, there appears significant overlap with possible difficulty in definite categorization. Taking into account the predominant phenotype, most patients had urticarial papular exanthem (55.6%), followed by morbilliform rash (27.8%) and erythroderma (11.1%). Facial edema extending till neck has been especially associated with DRESS and a good proportion of patients present with purpuric and pustular lesions in addition to the predominant phenotype. Blood eosinophilia, atypical lymphocytes in peripheral blood, deranged liver and renal functions, lymphadenopathy, and pericarditis are important diagnostic hallmarks of DRESS having a place in the RegiSCAR score; however, none appears exclusive.[8] Blood eosinophilia was reported in 55.6% of our cases. Ortonne et al.[7] and Skowron et al.[6] reported higher proportion of patients with blood eosinophilia ranging from 89% to 97%. Variable representation of systemic involvement between studies also reflects the level of care available at different institutes. In the study by Walsh et al.,[1] all cases had liver involvement and was attributed to theirs being a tertiary referral center for hepatobiliary diseases. Histopathology of DRESS has not been well specified and is labeled as EM-like, spongiotic, lichenoid, or toxic epidermal necrolysis like, which in turn reflects the variable clinical phenotype.[7] Whether a particular histopathological pattern or character predicts systemic involvement and thus disease severity is also debatable. Presence of apoptotic or dyskeratotic keratinocytes has achieved significant attention with most studies correlating it with liver and renal dysfunction.[57] Drug-induced liver injury involves acute hepatocellular necrosis mirroring keratinocyte apoptosis. This is mediated by activated T-cells resulting in perforin granzyme B and Fas/Fas ligand-dependent cell death in both liver and skin.[91011] In the present study, however, such association could not be established (P > 0.05). Further, none of the histopathological features correlated with systemic involvement except for papillary dermal edema, which was associated with renal involvement (P = 0.01). Since DRESS can have variable clinical presentation and at times, differentiation from the benign MPDR can be challenging. Histopathology can help differentiate the two up to some extent with resultant better management. Significant findings favoring DRESS included severe spongiosis, lymphocyte exocytosis, interface vacuolization, papillary dermal edema, and moderate to severe density of perivascular dermal infiltrate. Ortonne et al.[7] also reported higher proportion of DRESS patients with interface dermatitis, dense dermal infiltrate, and atypical lymphocytes [Table 5]. In the present study though more cases with DRESS exhibited apoptotic keratinocytes; however, it failed to attain statistical significance. Chi et al.[5] reported dyskeratosis, spongiosis, and basal vacuolar damage as important features differentiating DRESS from MPDR. They further reported the most common histopathological pattern in MPDR to be lichenoid (71%) followed by EM like (18%) and nonspecific (12%). Ortonne et al.[7] suggested identification of multiple patterns in one biopsy as a strong predictor of DRESS. We support their findings, with two-third of our cases having multiple histopathology patterns. Most common combination seen was eczematous with lichenoid in our series. Such combined patterns were inconspicuous in MPDR.
Table 5

Comparison of histopathology of DRESS among reported studies

Histopathology characteristics (%)Present study (n=18)Ortonne et al.[7] (n=50)Walsh et al.[1] (n=27)Skowron et al.[6] (n=45)Sasidharanpillai et al.[4] (n=9)Chi et al.[5] (n=32)
Epidermal spongiosis99.4-59.25555.578
Epidermal dyskeratosis33.36033.34222.297
Lymphocyte exocytosis88.964--44.491
Interface vacuolization77.87633.33355.591
Papillary dermal edema10048--44.466
Eosinophilia95.4%20-8433.372
RBC extravasation55.5-88.846-53
Superficial and deep dermal infiltrate50.026-4133.3-
Atypical lymphocytes11.128-3622.2-
Density of dermal infiltrate (moderate to severe)83.358----
Comparison of histopathology of DRESS among reported studies Many patients of MPDR also manifest systemic involvement ranging from deranged liver and renal function to blood eosinophilia; however, as they fail to achieve a RegiSCAR score of four or above, they are not classified as DRESS. Similarly, some patients of DRESS do not manifest systemic derangements. As there is therapeutic significance of systemic involvement, it is worthwhile to identify whether specific histopathological characters can predict it. In the reported study, lymphocyte exocytosis, presence of both superficial as well as deep dermal inflammatory infiltrate that is moderate to severe in density correlated significantly with deranged kidney function. However, such association could not be established with deranged liver function. Thus, histopathology revealing prominent basal vacuolization, spongiosis, and dense dermal infiltrate is suggestive of DRESS. Presence of multiple histopathological patterns in a single biopsy should also be helpful in differentiating DRESS and MPDR. Presence of lymphocyte exocytosis (>10 lymphocytes/40X in minimum three fields), superficial and deep dermal infiltrate that is moderate to severe in density helps predict renal involvement in patients presenting with drug rash. The main limitations of the study are limited sample size and absence of objective assessment of histopathology characters including spongiosis, lymphocyte exocytosis, dermal edema, dermal infiltration, and basal vacuolization.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  11 in total

Review 1.  Liver immunobiology.

Authors:  George A Parker; Catherine A Picut
Journal:  Toxicol Pathol       Date:  2005       Impact factor: 1.902

2.  Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis.

Authors:  Sarita Sasidharanpillai; Aparna Govindan; Najeeba Riyaz; Manikoth P Binitha; Kunnummal Muhammed; Anza Khader; Olasseri K Reena Mariyath; Muhammedkutty Simin; Kunnari Subin
Journal:  Indian J Dermatol Venereol Leprol       Date:  2016 Jan-Feb       Impact factor: 2.545

3.  Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity.

Authors:  Sinforiano J Posadas; Antonia Padial; Maria J Torres; Cristobalina Mayorga; Laura Leyva; Elena Sanchez; Javier Alvarez; Antonino Romano; Carlos Juarez; Miguel Blanca
Journal:  J Allergy Clin Immunol       Date:  2002-01       Impact factor: 10.793

4.  Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases.

Authors:  F Skowron; B Bensaid; B Balme; L Depaepe; J Kanitakis; A Nosbaum; D Maucort-Boulch; F Bérard; M D'Incan; S H Kardaun; J F Nicolas
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-09-09       Impact factor: 6.166

Review 5.  Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

Authors:  H Bocquet; M Bagot; J C Roujeau
Journal:  Semin Cutan Med Surg       Date:  1996-12

6.  Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.

Authors:  S H Kardaun; P Sekula; L Valeyrie-Allanore; Y Liss; C Y Chu; D Creamer; A Sidoroff; L Naldi; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2013-11       Impact factor: 9.302

Review 7.  Cellular and molecular pathophysiology of cutaneous drug reactions.

Authors:  Werner J Pichler; Nikhil Yawalkar; Markus Britschgi; Jan Depta; Ingrid Strasser; Simone Schmid; Petra Kuechler; Dean Naisbitt
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

Review 8.  The DRESS syndrome: a literature review.

Authors:  Patrice Cacoub; Philippe Musette; Vincent Descamps; Olivier Meyer; Chris Speirs; Laetitia Finzi; Jean Claude Roujeau
Journal:  Am J Med       Date:  2011-05-17       Impact factor: 4.965

9.  Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS).

Authors:  M-H Chi; R C-Y Hui; C-H Yang; J-Y Lin; Y-T Lin; H-C Ho; W-H Chung; T-T Kuo
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

10.  Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.

Authors:  S Walsh; S Diaz-Cano; E Higgins; R Morris-Jones; S Bashir; W Bernal; D Creamer
Journal:  Br J Dermatol       Date:  2013-02       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.